Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sovia Altis is a prominent Indian pharmaceutical company operating as a division of Gopal Lifesciences. Established in 2006 and headquartered in Panchkula, Haryana, the company specializes in manufacturing, marketing, and distributing a comprehensive range of pharmaceutical products, including allopathic, Ayurvedic, nutraceutical, and cosmetic dermatological formulations. Operating from a WHO-GMP, ISO 9001:2015, and GLP-certified manufacturing facility in Baddi, Himachal Pradesh, Sovia Altis offers PCD Pharma Franchise opportunities and third-party manufacturing services across India. Its extensive product portfolio of over 150 formulations includes tablets, capsules, liquid orals, dry syrups, injectables, and topical creams covering diverse therapeutic segments such as analgesics, antibiotics, anti-diabetics, and anti-hypertensives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sovia Altis.